Adam Elsesser sold $17M of PEN
CEO and President at Penumbra Inc. 61,600 shares at an average of $283.59, traded Mar 5, 2025, filed Mar 7, 2025.
Score components
- +25RoleCEO
- +25Trade size$17.5M at market
- +20Share of holdings soldSold 79% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.6%, 3m -5.8%, 6m +2.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001321732-25-000048, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 5, 2025 | MOption exercise Common Stock10b5-1 | +72,976 | $30.00 | $2.2M | 77,976 | Mar 7, 2025 |
| Mar 5, 2025 | SOpen-market sale Common Stock10b5-1 | -5,668 | $281.14 | $1.6M | 72,308 | Mar 7, 2025 |
| Mar 5, 2025 | SOpen-market sale Common Stock10b5-1 | -7,467 | $282.25 | $2.1M | 64,841 | Mar 7, 2025 |
| Mar 5, 2025 | SOpen-market sale Common Stock10b5-1 | -19,865 | $283.15 | $5.6M | 44,976 | Mar 7, 2025 |
| Mar 5, 2025 | SOpen-market sale Common Stock10b5-1 | -10,874 | $284.16 | $3.1M | 34,102 | Mar 7, 2025 |
| Mar 5, 2025 | SOpen-market sale Common Stock10b5-1 | -17,626 | $285.06 | $5.0M | 16,476 | Mar 7, 2025 |
| Mar 5, 2025 | SOpen-market sale Common Stock10b5-1 | -100 | $286.57 | $29k | 16,376 | Mar 7, 2025 |
| Mar 5, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -72,976 | $0.00 | $0 | 377,024 | Mar 7, 2025 |
Related signals
Other insiders at Penumbra Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 1Weak | Penumbra Inc | Harpreet Grewal director | $33k 100 shares | -1% | |
| 30Weak | Penumbra Inc | Maggie Yuen Chief Financial Officer | $832k 2,432 shares | -12% | |
| 10Weak | Penumbra Inc | Harpreet Grewal director | $58k 186 shares | -2% | |
| 30Weak | Penumbra Inc | Thomas Wilder director | $58k 186 shares | -100% | |
| 35Weak | Penumbra Inc | Arani Bose director | $4.6M 15,000 shares | -5% | |
| 19Weak | Penumbra Inc | Johanna Roberts EVP, Gen. Counsel & Secretary | $90k 300 shares | -0% | |
| 15Weak | Penumbra Inc | Harpreet Grewal director | $29k 100 shares | -1% | |
| 22Weak | Penumbra Inc | Johanna Roberts EVP, Gen. Counsel & Secretary | $177k 600 shares | -1% | |
| 35Weak | Penumbra Inc | Arani Bose director | $2.3M 7,500 shares | -3% | |
| 29Weak | Penumbra Inc | Johanna Roberts EVP, Gen. Counsel & Secretary | $540k 1,800 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.